Concepedia

Haobin Deng

HD

4

Publications

130

Citations

4

H-Index

2021

Active since

Affiliations

Tianjin First Center Hospital(Current)

Tianjin Medical University

Nankai University

Tianjin Medical University Cancer Institute and Hospital

Haobin Deng is an author at Tianjin First Center Hospital specializing in tumor immunity, autoimmunity, and t cell immunity.

ORCID

Top concepts

Publications per year

2021–2022

4

Publications

4

Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease

Haobin Deng, Meijing Liu, Ting Yuan et al. · Frontiers in Immunology · 2021 · 54 citations · Full text

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma

Meijing Liu, Haobin Deng, Juan Mu et al. · Cancer Science · 2021 · 38 citations · Full text

Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy

Haibo Zhu, Haobin Deng, Juan Mu et al. · OncoTargets and Therapy · 2021 · 26 citations · Full text

Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti‐CD19‐chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B‐cell lymphoma and high tumor burden

Juan Mu, Haobin Deng, Cuicui Lyu et al. · Hematological Oncology · 2022 · 12 citations

, , +16

Rows per page

1–4 of 4